Newron Pharmaceuticals S.p.A.
$20.00+0.00%(+$0.00)
TickerSpark Score
72/100
70
Valuation
60
Profitability
100
Growth
28
Health
100
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NWPHF research report →
52-Week Range100% of range
Low $9.36
Current $20.00
High $20.00
Companywww.newron.com
Newron Pharmaceuticals S. p. A.
- CEO
- Stefan Weber
- IPO
- 2017
- Employees
- 22
- HQ
- Bresso, MI, IT
Price Chart
+221.54% · this period
Valuation
- Market Cap
- $416.12M
- P/E
- -24.00
- P/S
- 17.33
- P/B
- -28.60
- EV/EBITDA
- -78.87
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 99.94%
- Op Margin
- -24.59%
- Net Margin
- -69.29%
- ROE
- 277.88%
- ROIC
- -17.13%
Growth & Income
- Revenue
- $51.39M · 467.41%
- Net Income
- $15.84M · 197.65%
- EPS
- $0.85 · 193.41%
- Op Income
- $26.17M
- FCF YoY
- -73.65%
Performance & Tape
- 52W High
- $20.00
- 52W Low
- $9.36
- 50D MA
- $17.02
- 200D MA
- $11.28
- Beta
- 0.78
- Avg Volume
- 1
Get TickerSpark's AI analysis on NWPHF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our NWPHF Coverage
We haven't published any research on NWPHF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NWPHF Report →